VenkatRamPeddiMD

Nephrology • San Francisco, CA

Physician

Join to view full profile

Dr. Peddi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Peddi's full profile

Already have an account?

Office
1100 Van Ness Ave
San Francisco, CA 94109
Phone+1 415-600-1063

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Nephrology, 1993 - 1995
Gandhi Medical CollegeClass of 1986

Certifications & Licensure

CA State Medical License 2003 - 2025
OH State Medical License 1995 - 2004
PA State Medical License 2001 - 2004
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Fellow (FAST) American Society of Transplantation
Fellow (FASN) American Society of Nephrology

Clinical Trials

Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic Start of enrollment: 2007 May 01
Completed
Phase 4
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx Start of enrollment: 2021 Oct 14
Recruiting
Phase 3
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

5 citations
Serial Peripheral Blood Gene Expression Profiling to Assess Immune Quiescence in Kidney Transplant Recipients with Stable Renal Function.
V. Ram Peddi, Parul Patel, C. Schieve, Stan Rose, M Roy First
Annals of Transplantation. 2020-04-28
24 citations
A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti‐CD40 monoclonal antibody, in kidney...
Flavio Vincenti, Goran B. Klintmalm, Harold Yang, V. Ram Peddi, Paul Blahunka
American Journal of Transplantation. 2020-01-01
39 citations
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-s...
Flavio Vincenti, Klemens Budde, Pierre Merville, Fuad S. Shihab, V. Ram Peddi
American Journal of Transplantation. 2018-12-01

Professional Memberships

American Society of Nephrology - ASN
Fellow